Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety

Clinical trial NCT00621270 · COMPLETED

Trial details

NCT number: NCT00621270
Sponsor: BrainCells Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Anxiety

Start date: 2008-01-01
Primary completion: 2009-10-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.